ANBC, INC. (SYUP)

Market Cap	23.88K +200.0%
Revenue (ttm)	50.95K -83.7%
Net Income	-382.25K
EPS	n/a
Shares Out	79.60M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,125
Open	0.0003
Previous Close	n/a
Day's Range	0.0003 - 0.0003
52-Week Range	0.0001 - 0.0003
Beta	-6.08
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About ANBC, INC.

ANBC, INC. engages in the development, manufacturing, and commercialization of traditional Chinese herbal medicines and biological pharmaceuticals in the People’s Republic of China. Its products primarily include Qilisheng a product formulated to be a general health enhancer by fortifying the immune system; Qi-ju-di-huang, an oral solution that protects the kidney and the liver; Qing-re-jie-du, an oral solution that reduces fever and relieves heat; Sheng-mai-yin, a solution that protects energy and enhances body fluids; Xiao-qing-long, an oral ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2003
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: SYUP

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 25, 2026

Data Sources Report a data error